Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline in Ischemic Stroke
NCT06210646Phase 3Completed
- Sponsor
- Kafrelsheikh University
- Start
- Dec 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of citicoline in ischemic stroke, sponsored by Kafrelsheikh University. Started Dec 2022; status: completed.
02
Drugs
citicoline
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT06210646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06210646.